NASDAQ: RPTX
Repare Therapeutics Inc Stock Ownership - Who owns Repare Therapeutics?

Insider buying vs selling

Have Repare Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ForteEVP CHIEF FINANCIAL OFFICER2025-03-126,884$1.14
$7.85kSell
Maria KoehlerEVP CHIEF MEDICAL OFFICER2025-03-123,596$1.14
$4.10kSell
Lloyd Mitchell SegalPRESIDENT AND CEO2025-03-1221,179$1.14
$24.14kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2025-03-125,611$1.14
$6.40kSell

1 of 1

RPTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPTX insiders and whales buy or sell their stock.

RPTX Shareholders

What type of owners hold Repare Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc24.31%10,333,600$12.40MInstitution
Ansbert Gadicke9.13%3,882,485$4.66MInsider
Davis Jerel8.65%3,675,793$4.41MInsider
Versant Vantage I LP8.59%3,650,662$4.38MInsider
Versant Ventures V LLC8.59%3,650,662$4.38MInsider
Blue Owl Capital Holdings LP8.10%3,443,659$4.13MInstitution
Orbimed Advisors LLC7.82%3,322,488$3.99MInstitution
Mpm Bioventures 2014 LP7.07%3,003,772$3.60MInsider
Versant Venture Management LLC6.23%2,646,657$3.18MInstitution
Todd Foley5.28%2,242,636$2.69MInsider

1 of 3

RPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPTX56.85%43.15%Net SellingNet Selling
FBLG15.74%16.01%Net Buying
PEPG76.44%18.61%Net BuyingNet Buying
SER0.80%99.20%Net BuyingNet Buying
IMRX11.99%38.68%Net Buying

Repare Therapeutics Stock Ownership FAQ

Who owns Repare Therapeutics?

Repare Therapeutics (NASDAQ: RPTX) is owned by 72.05% institutional shareholders, 54.69% Repare Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Repare Therapeutics shareholder, owning 3.88M shares representing 9.13% of the company. Ansbert Gadicke's Repare Therapeutics shares are currently valued at $4.66M.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.